Connect with us


Australia Secures Access to “Promising” Covid-19 Vaccine, Will Be Given Free To Entire Population




  • The Australian government has signed a deal to secure “early access” for the coronavirus vaccine being developed by drug company AstraZeneca and the Oxford University.
  • Once proven effective in clinical trials, the cure will be given for free to the country’s entire population as Prime Minister Scott Morrison said that it will be “mandatory.
  • Currently, Australia has over 24,000 confirmed. Covid-19 cases. With more than 450 deaths.

According to recent reports, the Australia has made a deal with pharmaceutical giant AstraZeneca and Oxford University for a coronavirus vaccine. Once proven effective in its clinical trials, the drug would be given to the entire 25 million Australian population for free.

Prime Minister Scott Morrison said that the deal will secure “early access for every Australian,” a welcome news for the country as it has so far recorded 450 deaths and almost 24,000 confirmed infections.

Morrison promised:

“If this vaccine proves successful, we will manufacture and supply vaccines straight away under our own steam and make it free for 25 million Australians.”

Meanwhile, a report also tells us that the cure is expected to arrive early next year.

In a radio interview with 3AW interview, the Prime Minister emphasized that he really wants the vaccine to be “as mandatory as you can possibly make it.”

He further elaborated:

“There are always exemptions for any vaccine on medical grounds but that should be the only basis.

“I mean we’re talking about a pandemic that has destroyed the global economy and taken the lives of hundreds of thousands all around the world and over 450 Australians here.

“We need the most extensive and comprehensive response to this to get Australia back to normal.”

Along with AstraZeneca, the government is also tapping American company Becton Dickinson to provide 100 million needles and syringes for a deal worth AU$25 million.

Watch this video report:
View Comments